Следене
Jennifer Van Eyk
Jennifer Van Eyk
Потвърден имейл адрес: cshs.org
Заглавие
Позовавания
Позовавания
Година
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
P Gao, I Tchernyshyov, TC Chang, YS Lee, K Kita, T Ochi, KI Zeller, ...
Nature 458 (7239), 762-765, 2009
22642009
Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology: a scientific statement from the American …
P Kligfield, LS Gettes, JJ Bailey, R Childers, BJ Deal, EW Hancock, ...
Circulation 115 (10), 1306-1324, 2007
15772007
Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide
FD Sonnichsen, JE Van Eyk, RS Hodges, BD Sykes
Biochemistry 31 (37), 8790-8798, 1992
7861992
How many human proteoforms are there?
R Aebersold, JN Agar, IJ Amster, MS Baker, CR Bertozzi, ES Boja, ...
Nature chemical biology 14 (3), 206-214, 2018
7452018
Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane
W Xu, Y Liu, S Wang, T McDonald, JE Van Eyk, A Sidor, B O'Rourke
Science 298 (5595), 1029-1033, 2002
5802002
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
JE Ebinger, J Fert-Bober, I Printsev, M Wu, N Sun, JC Prostko, EC Frias, ...
Nature medicine 27 (6), 981-984, 2021
5582021
Genome-wide analyses identify KIF5A as a novel ALS gene
A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ...
Neuron 97 (6), 1268-1283. e6, 2018
5582018
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
5452014
Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm
ME Lindsay, D Schepers, NA Bolar, JJ Doyle, E Gallo, J Fert-Bober, ...
Nature genetics 44 (8), 922-927, 2012
4732012
Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized …
KA Ellenbogen, MR Gold, TE Meyer, I Fernndez Lozano, S Mittal, ...
Circulation 122 (25), 2660-2668, 2010
4682010
Guidelines for experimental models of myocardial ischemia and infarction
ML Lindsey, R Bolli, JM Canty Jr, XJ Du, NG Frangogiannis, S Frantz, ...
American Journal of Physiology-Heart and Circulatory Physiology 314 (4 …, 2018
4632018
Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications
GD Vatine, R Barrile, MJ Workman, S Sances, BK Barriga, M Rahnama, ...
Cell stem cell 24 (6), 995-1005. e6, 2019
4262019
Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction
R Labugger, L Organ, C Collier, D Atar, JE Van Eyk
Circulation 102 (11), 1221-1226, 2000
4202000
Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury
JL McDonough, DK Arrell, JE Van Eyk
Circulation research 84 (1), 9-20, 1999
4091999
Preparation of proteins and peptides for mass spectrometry analysis in a bottom‐up proteomics workflow
RL Gundry, MY White, CI Murray, LA Kane, Q Fu, BA Stanley, JE Van Eyk
Current protocols in molecular biology 90 (1), 10.25. 1-10.25. 23, 2010
3992010
Guidelines for the next 10 years of proteomics
MR Wilkins, RD Appel, JE Van Eyk, MCM Chung, A Görg, M Hecker, ...
Proteomics 6 (1), 4-8, 2006
3872006
The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations
AB Keenan, SL Jenkins, KM Jagodnik, S Koplev, E He, D Torre, Z Wang, ...
Cell systems 6 (1), 13-24, 2018
3852018
A mass spectrometric-derived cell surface protein atlas
D Bausch-Fluck, A Hofmann, T Bock, AP Frei, F Cerciello, A Jacobs, ...
PloS one 10 (4), e0121314, 2015
3832015
Clinical proteomics: a need to define the field and to begin to set adequate standards
H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ...
PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007
3572007
Circulating transforming growth factor-β in Marfan syndrome
P Matt, F Schoenhoff, J Habashi, T Holm, C Van Erp, D Loch, OD Carlson, ...
Circulation 120 (6), 526-532, 2009
3402009
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20